134 related articles for article (PubMed ID: 22646816)
21. The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study.
Turk T; Saad AM; Al-Husseini MJ; Gad MM
Curr Probl Cancer; 2020 Apr; 44(2):100511. PubMed ID: 32115255
[TBL] [Abstract][Full Text] [Related]
22. Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades.
Alabrach Y; Mahmoud AA; Abdelhay A; Mansour M; Adra S
Expert Rev Hematol; 2023; 16(10):785-791. PubMed ID: 37515515
[TBL] [Abstract][Full Text] [Related]
23. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
Jamroziak K; Szemraj Z; Grzybowska-Izydorczyk O; Szemraj J; Bieniasz M; Cebula B; Giannopoulos K; Balcerczak E; Jesionek-Kupnicka D; Kowal M; Kostyra A; Calbecka M; Wawrzyniak E; Mirowski M; Kordek R; Robak T
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):945-53. PubMed ID: 19240243
[TBL] [Abstract][Full Text] [Related]
24. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
[TBL] [Abstract][Full Text] [Related]
25. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
[TBL] [Abstract][Full Text] [Related]
26. Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
Huang SJ; Chan J; Bruyère H; Allan LL; Gerrie AS; Toze CL
Leuk Res; 2019 Sep; 84():106193. PubMed ID: 31325731
[TBL] [Abstract][Full Text] [Related]
27. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
[TBL] [Abstract][Full Text] [Related]
28. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
29. Improving but inferior survival in patients with chronic lymphocytic leukemia in taiwan: a population-based study, 1990-2004.
Wu SJ; Chiang CJ; Lin CT; Tien HF; Lai MS
PLoS One; 2013; 8(4):e62930. PubMed ID: 23638168
[TBL] [Abstract][Full Text] [Related]
30. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
[TBL] [Abstract][Full Text] [Related]
31. Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia.
Radivoyevitch T; Sachs RK; Gale RP; Smith MR; Hill BT
Leuk Res; 2016 Apr; 43():9-12. PubMed ID: 26922774
[TBL] [Abstract][Full Text] [Related]
32. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Tsimberidou AM; Wen S; McLaughlin P; O'Brien S; Wierda WG; Lerner S; Strom S; Freireich EJ; Medeiros LJ; Kantarjian HM; Keating MJ
J Clin Oncol; 2009 Feb; 27(6):904-10. PubMed ID: 19114699
[TBL] [Abstract][Full Text] [Related]
33. The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era.
Nabhan C; Aschebrook-Kilfoy B; Chiu BC; Smith SM; Shanafelt TD; Evens AM; Kay NE
Leuk Lymphoma; 2014 Dec; 55(12):2778-84. PubMed ID: 24588735
[TBL] [Abstract][Full Text] [Related]
34. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
36. Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong.
Lan Q; Au WY; Chanock S; Tse J; Wong KF; Shen M; Siu LP; Yuenger J; Yeager M; Hosgood HD; Purdue MP; Liang R; Rothman N
Eur J Haematol; 2010 Dec; 85(6):492-5. PubMed ID: 20731705
[TBL] [Abstract][Full Text] [Related]
37. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data.
Lenartova A; Johannesen TB; Tjønnfjord GE
Cancer Med; 2016 Dec; 5(12):3588-3595. PubMed ID: 27925456
[TBL] [Abstract][Full Text] [Related]
38. Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period.
Utuama O; Mukhtar F; Pham YT; Dabo B; Manani P; Moser J; Michael-Asalu A; Tran CT; Le LC; Le TV; Vu KT; Park JY; Boffetta P; Zheng W; Shu XO; Luu HN
PLoS One; 2019; 14(8):e0220864. PubMed ID: 31425527
[TBL] [Abstract][Full Text] [Related]
39. Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States.
Kabadi SM; Goyal RK; Nagar SP; Kaye JA; Davis KL
Cancer Med; 2019 Jul; 8(8):3803-3810. PubMed ID: 31144473
[TBL] [Abstract][Full Text] [Related]
40. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
